SEP 03, 2015 11:38 PM PDT

Protecting Monkeys against MERS

For the first time a synthetic DNA vaccine can induce protective immunity against the Middle East Respiratory Syndrome (MERS) coronavirus in animal species, reported researchers from the Perelman School of Medicine at the University of Pennsylvania.
Synthetic DNA vaccine protects against MERS. 
David B. Weiner, Ph.D., a professor of pathology and laboratory medicine, and colleagues published their work in Science Translational Medicine (STM). Administered six weeks before exposure to the MERS virus, the experimental, preventive vaccine fully protected rhesus macaques from disease. It also generated potentially protective antibodies in blood taken from camels, the alleged source of MERS transmission in the Middle East.
 
MERS is caused by an emerging human coronavirus, which is different from the SARS coronavirus. Since it was identified in 2012, MERS has been linked to over 1,300 infections and nearly 400 deaths in the Arabian Peninsula, Europe and the U.S.
 
In the 2015 outbreak in South Korea, the infection spread from a single patient to more than 181 people, causing hospital closures, severe economic impact and more than 30 deaths. Rapid human-to-human transmission, especially in-hospital transmission, was the most common source of infection.
 
“The significant recent increase in MERS cases, coupled with the lack of effective antiviral therapies or vaccines to treat or prevent this infection, have raised significant concern,” Weiner said. “Accordingly the development of a vaccine for MERS remains a high priority.”
 
The vaccine prevented MERS disease in the monkeys and benefited 100 percent of the animals in this study in minimizing symptoms. It also induced antibodies that are associated with protection in camels, a species considered a major source of transmission to humans in the Middle East, demonstrating that this vaccine could be used to break the link in the MERS transmission cycle. In the field, the vaccine could decrease person-to-person spread of infection in an outbreak and help to protect health care workers or exposed individuals.
 
According to first author Karuppiah Muthumani, PhD, a research assistant professor of pathology and laboratory medicine, “This study was only possible by bringing together an international group of investigators with the necessary skills, including, the lab of Heinz Feldmann at the NIH, Gary Kobinger from the Canadian government, scientists from Inovio who developed the plasmid delivery technology, along with Penn colleagues. This simple synthetic vaccine has the potential to overcome important production and deployment limitations, and what’s more, the vaccine is non-live, so does not pose a risk of spreading to unintended individuals.” 
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 27, 2018
Immunology
NOV 27, 2018
A Genetic Switch During Inflammation
Microglia, CNS immune cells, change their genetic profile during different states of the inflammation spectrum...
DEC 01, 2018
Videos
DEC 01, 2018
Identifying Disease-causing Gene Mutations
Genetic diseases can be traced back to an error in a gene. This video explores how the process works....
DEC 21, 2018
Microbiology
DEC 21, 2018
How the Gut Microbiome Controls the Intestinal Immune System
The gut microbiome has many important functions, including helping us digest food. But it has to protect itself from the immune system....
JAN 03, 2019
Microbiology
JAN 03, 2019
Genetic Risk Factors Make Some People Susceptible to Common Microbes
Th mycobacteria family of microbes includes over 70 members, which are everywhere and are often harmless. But they make some people sick....
JAN 16, 2019
Genetics & Genomics
JAN 16, 2019
Gene Therapy for a Leading Cause of Infant Death is Closer to Market
New treatments for some diseases can have extremely high price tags. One example is Zolgensma, which might cost $5 million per patient....
JAN 22, 2019
Genetics & Genomics
JAN 22, 2019
Towards a Better Understanding of Genetic Modifications in Plants
Scientists have taken a close look at what happens on the molecular level when DNA is inserted into the genome of a plant....
Loading Comments...